Prosecution Insights
Last updated: November 20, 2026

Amy Marie Chattin, USPTO Patent Examiner

Listed by the USPTO as CHATTIN, AMY MARIE

Tech Center 1600 • Art Units: 1637 1642 1643 1644 1646

This examiner grants 71% of resolved cases

Analysis

CHATTIN, AMY MARIE is a USPTO patent examiner in Tech Center 1600 and Art Unit 1637. The profile includes 56 resolved cases, an allowance rate of 71.4%, and a median of 1380 days to allowance. Interview lift is 45.9%, showing a substantial association between interviews and allowance outcomes.

The listed companies are The Regents of the University of California, Genentech Inc., and Hoffmann-La Roche Inc. The leading firms are NORTON ROSE FULBRIGHT US LLP, WC&F IP, and Casimir Jones, S.C. The allowance rate provides useful historical context, while the 45.9% interview lift supports making interviews a deliberate part of response planning when issues can be resolved through discussion. The 56-case record is informative but limited, so practitioners should connect the statistics to the application’s technology and claim structure. The 1380-day median requires long-range docket management.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

71.4%
Allow Rate
+11.4% vs TC avg
104
Total Applications
+45.9%
Interview Lift
1380
Avg Prosecution Days
Based on 56 resolved cases, 2023–2026

Rejection Statute Breakdown

3.8%
§101 Eligibility
19.4%
§102 Novelty
32.1%
§103 Obviousness
32.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18612141 USES OF IL-13 ANTAGONISTS FOR TREATING ATOPIC DERMATITIS Non-Final OA GENENTECH, INC.
18553143 ANTIBODIES AGAINST CLEAVED CDCP1 AND USES THEREOF Non-Final OA The Regents of the University of California
18248189 MOTIF NEOEPITOPES FOR CANCER IMMUNOTHERAPY Final Rejection THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
17773283 DEGRADATION OF SURFACE PROTEINS USING BISPECIFIC BINDING AGENT Non-Final OA The Regents of the University of California
18066529 PROTEASE-ACTIVATED T CELL BISPECIFIC ANTIBODIES Non-Final OA Hoffmann-La Roche Inc.
19548088 METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST Non-Final OA REGENERON PHARMACEUTICALS, INC.
18252928 ANTI-CD6 ANTIBODY CONJUGATES FOR TREATING T-CELL MEDIATED DISORDERS AND T-CELL LYMPHOMA/LEUKEMIA Final Rejection The Cleveland Clinic Foundation
17765585 METHODS AND COMBINATIONS FOR THE TREATMENT OF CANCER USING IMMUNE CHECKPOINT INHIBITOR ANTIBODIES Final Rejection ASTRAZENECA AB
18481725 COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC ANTIGEN RECEPTORS TARGETING CLAUDIN 18.2 Non-Final OA MEDIMMUNE, LLC
17802794 ANTIGEN-PRESENTING EXTRACELLULAR VESICLES, COMPOSITION CONTAINING SAME, AND METHOD FOR PRODUCTION THEREOF Final Rejection NISSAN CHEMICAL CORPORATION
18324012 COMPOSITIONS AND METHODS FOR PREPARING ENGINEERED LYMPHOCYTES FOR CELL THERAPY Final Rejection Kite Pharma, Inc.
17787094 MULTI-SPECIFIC ANTIBODIES Non-Final OA UCB BIOPHARMA SRL
18686868 CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY PLATFORM Non-Final OA The Research Institute at Nationwide Children's Hospital

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Amy Marie Chattin's allowance rate?

71.4% of resolved applications examined by Amy Marie Chattin were allowed (56 resolved cases), compared with 44.9% across Art Unit 1637 over the last five years.

Does an interview help with examiner Amy Marie Chattin?

This examiner's interview lift is +45.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Amy Marie Chattin take to allow a patent?

Applications allowed by Amy Marie Chattin took 1,380 days on average from filing to allowance.

Which art unit does examiner Amy Marie Chattin work in?

Amy Marie Chattin examines applications in Art Unit 1637 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month